A Phase 1 study of AMG 691 in healthy and asthmatic participants

Study Description

Evaluating the safety and tolerability of an investigational drug, AMG 691, in healthy individuals and those with mild-to-moderate asthma

Study Details

Registry ID:

NCT06637371

Conditions:

Asthma

Phase:

Phase 1

Target Enrollment:

21 participants

Start Date:

October 16, 2024

Age Range:

18–70 years

Healthy Volunteers:

No

Study Locations (22 sites)

• Algemeen Ziekenhuis Sint Maarten-Emmaus vzw
  MechelenBelgium, Belgium
• Algemeen Ziekenhuis Sint-Maarten
  MechelenBelgium, Belgium
• Chelsea and Westminster Hospital
  LondonUnited Kingdom, United Kingdom
• VPD Heart and Lung Research Institute
  CambridgeUnited Kingdom, United Kingdom
• The Medicines Evaluation Unit
  ManchesterUnited Kingdom, United Kingdom
• Mayflower Clinical
  South Dartmouth, MassachusettsUnited States, United States
• Brigham and Womens Hospital
  Boston, MassachusettsUnited States, United States
• Translational Clinical Research LLC
  Aventura, FloridaUnited States, United States
• Destiny Research Center
  Palmetto Bay, FloridaUnited States, United States
• Chesapeake Clinical Research Inc
  White Marsh, MarylandUnited States, United States
• North Carolina Clinical Research
  Raleigh, North CarolinaUnited States, United States
• Monroe Biomedical Research
  North Charleston, South CarolinaUnited States, United States
• University of North Carolina Clinical and Translational Research Center
  Chapel Hill, North CarolinaUnited States, United States
• Winchester District Memorial Hospital
  Winchester, OntarioCanada, Canada
• Monroe Biomedical Research
  Monroe, North CarolinaUnited States, United States
• ClinCept, LLC
  Columbus, GeorgiaUnited States, United States
• Mayo Clinic
  Rochester, MinnesotaUnited States, United States
• Endeavor Clinical Trials
  San Antonio, TexasUnited States, United States
• Prism Research LLC dba Nucleus Network
  Saint Paul, MinnesotaUnited States, United States
• Allergy Asthma and Clinical Research Center
  Oklahoma City, OklahomaUnited States, United States
• Orange County Research Center
  Lake Forest, CaliforniaUnited States, United States
• Clinical Medical and Analytical eXellence CMAX
  Adelaide, South AustraliaAustralia, Australia

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →